250 related articles for article (PubMed ID: 8306756)
1. Erythromycin does not directly affect neutrophil functions.
Hojo M; Fujita I; Hamasaki Y; Miyazaki M; Miyazaki S
Chest; 1994 Feb; 105(2):520-3. PubMed ID: 8306756
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma.
Miyatake H; Suzuki K; Taki F; Takagi K; Satake T
Arzneimittelforschung; 1991 May; 41(5):552-6. PubMed ID: 1654910
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.
Anderson R
J Infect Dis; 1989 May; 159(5):966-73. PubMed ID: 2540250
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cellular cytosolic calcium and chemotactic peptide binding by an inhibitor of neutrophil function.
Cooper JA; Bridges TA; Kennedy JI; Culbreth R
Am J Physiol; 1994 Jul; 267(1 Pt 1):L71-8. PubMed ID: 8048544
[TBL] [Abstract][Full Text] [Related]
5. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
Stenson WF; Mehta J; Spilberg I
Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcium antagonists on the activation of guinea pig neutrophils.
Azuma Y; Tokunaga T; Takeda Y; Ogawa T; Takagi N
Jpn J Pharmacol; 1986 Oct; 42(2):243-51. PubMed ID: 3025491
[TBL] [Abstract][Full Text] [Related]
7. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
[TBL] [Abstract][Full Text] [Related]
8. Estradiol inhibits fMLP-induced neutrophil migration and superoxide production by upregulating MKP-2 and dephosphorylating ERK.
Zhang P; Fu Y; Ju J; Wan D; Su H; Wang Z; Rui H; Jin Q; Le Y; Hou R
Int Immunopharmacol; 2019 Oct; 75():105787. PubMed ID: 31401382
[TBL] [Abstract][Full Text] [Related]
9. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
11. Normal oxidative activity and chemotaxis of circulating neutrophils in patients treated with photopheresis.
Obel N; Storgaard M; Hansen B; Zachariae H
Arch Dermatol Res; 1994; 286(1):18-20. PubMed ID: 8141608
[TBL] [Abstract][Full Text] [Related]
12. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
14. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
[TBL] [Abstract][Full Text] [Related]
15. Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes.
Villagrasa V; Berto L; Cortijo J; Perpina M; Sanz C; Morcillo EJ
Gen Pharmacol; 1997 Oct; 29(4):605-9. PubMed ID: 9352310
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
Farmer JC; Burkey TH; Kew RR; Webster RO
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: differential inhibition of responses to a variety of stimuli.
Wright CD; Hoffman MD; Thueson DO; Conroy MC
J Leukoc Biol; 1987 Jul; 42(1):30-5. PubMed ID: 2439626
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide.
Mitsuyama T; Hidaka K; Furuno T; Hara N
Int Arch Allergy Immunol; 1997 Oct; 114(2):111-5. PubMed ID: 9338603
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of furosemide on activation of human peripheral blood polymorphonuclear leukocytes stimulated with n-formyl-methionyl-leucyl-phenylalanine.
Bialasiewicz P; Wlodarczyk A; Dudkiewicz B; Nowak D
Int Immunopharmacol; 2004 Jun; 4(6):819-31. PubMed ID: 15135322
[TBL] [Abstract][Full Text] [Related]
20. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
